Unknown NA INTERVENTIONAL 2-arm NCT03104920

ERAS Program Improves Recovery of HCC Patient Undergoing Hepatectomy

ERAS (Early Recovery After Surgery) Program Improve the Recovery of the Patient Undergoing Curative Hepatectomy: a Prospective Multicenter Cohort Trial

Sponsor: feng xiaobin

Conditions HCC

Interventions ERAS Program Traditional treatment

Updated 6 times since 2017 Last updated: Apr 1, 2017 Started: Mar 27, 2017 Primary completion: Sep 30, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on HCC, this trial is ongoing. The trial is conducted by feng xiaobin and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Apr 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Apr 2019 [monthly]

Recruiting NA

▶ Show 1 earlier version

May 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

feng xiaobin

Data source: Southwest Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China